KTC1101 | MedChemExpress (MCE)

KTC1101 is an orally active pan-PI3K inhibitor. KTC1101 can inhibit the PI3K signaling pathway, reduce downstream AKT and mTOR phosphorylation, and reduces the expression of Ki67. The anti-tumor effect of KTC1101 has a dual mechanism of action: directly inhibiting tumor cell growth and dynamically enhancing immune response[1].

Trivial name KTC1101
Catalog Number HY-162382
Research Area Cancer
CAS# 2764833-47-6
Purity ≥98.0%
SMILES FC(F)C1=NC2=C(OC)C=C(N)C=C2N1C3=NC(N4CCOCCC4)=NC(N5CCOCC5)=N3
Size 1 mg
Supplier Page https://www.medchemexpress.com/ktc1101.html